Learn More
Medchemexpress LLC HS-276 | 2767422-72-8 | 98.9% | 419.52 | 50 MG

Supplier: Medchemexpress LLC HY14714150MG
HS-276 is an orally active, potent, and highly selective TAK1 inhibitor. It significantly inhibits multiple kinases including TAK1, CLK2, GCK, ULK2, MAP4K5, IRAK1, NUAK, CSNK1G2, CAMKKβ-1, and MLK1. This compound can be utilized for rheumatoid arthritis (RA) research, reducing the expression of TNF, IL-6, and IL-1β in a dose-dependent manner. In vivo studies have shown its effectiveness in reducing inflammation and related histological manifestations in a CIA mouse model of inflammatory arthritis.
- Potent and selective TAK1 inhibitor with a Ki of 2.5 nM
- Inhibits multiple kinases including CLK2, GCK, ULK2, MAP4K5, IRAK1, NUAK, CSNK1G2, CAMKKβ-1, and MLK1
- Reduces expression of TNF, IL-6, and IL-1β in vitro
- Effective in a CIA mouse model of inflammatory arthritis, reducing inflammation and bone damage
- Exhibits excellent bioavailability in CD-1 mice
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.